Principal Financial Group
IMVT icon

Principal Financial Group’s Immunovant IMVT Stock Holding History

Principal Financial Group’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-760,608
Closed -$13M – 2268
2025
Q1 		$13M Sell
760,608
-31,255
-4% -$654K 0.01% 1114
2024
Q4 		$19.6M Sell
791,863
-159,261
-17% -$4.52M 0.01% 861
2024
Q3 		$27.1M Buy
951,124
+391,436
+70% +$11.5M 0.01% 682
2024
Q2 		$14.8M Sell
559,688
-23,033
-4% -$655K 0.01% 1047
2024
Q1 		$18.8M Buy
582,721
+142,606
+32% +$5.2M 0.01% 944
2023
Q4 		$18.5M Buy
440,115
+113,040
+35% +$4.16M 0.01% 925
2023
Q3 		$12.6M Buy
327,075
+303,707
+1,300% +$6.86M 0.01% 1093
2023
Q2 		$443K Sell
23,368
-684
-3% -$12.8K ﹤0.01% 1980
2023
Q1 		$373K Buy
24,052
+1,319
+6% +$22.9K ﹤0.01% 2037
2022
Q4 		$404K Buy
22,733
+4,896
+27% +$61.6K ﹤0.01% 2025
2022
Q3 		$99K Buy
17,837
+2,510
+16% +$12.3K ﹤0.01% 2336
2022
Q2 		$60K Buy
15,327
+2,293
+18% +$9.9K ﹤0.01% 2448
2022
Q1 		$72K Sell
13,034
-734
-5% -$4.57K ﹤0.01% 2458
2021
Q4 		$117K Sell
13,768
-5,694
-29% -$47K ﹤0.01% 2426
2021
Q3 		$169K Sell
19,462
-3,155
-14% -$28.5K ﹤0.01% 2452
2021
Q2 		$239K Buy
22,617
+3,094
+16% +$43.2K ﹤0.01% 2425
2021
Q1 		$313K Sell
19,523
-8,121
-29% -$214K ﹤0.01% 2265
2020
Q4 		$1.28M Buy
+27,644
New +$1.28M ﹤0.01% 1888

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AGM
Alpine Global Management New York $668M AUM 20.22% 1-Year Est. Return

Principal Financial Group's IMVT Position: Q2 2025 in Review

Principal Financial Group sold out of Immunovant (IMVT) in Q2 2025, closing a stake of 760,608 shares — an estimated $13M sold.

Principal Financial Group first reported a position in IMVT in Q4 2020 and held it in 18 quarters. The position peaked at $27.1M in Q3 2024. 168 funds tracked by Wall St. Rank hold IMVT as of Q2 2025.

  • Principal Financial Group reported no remaining Immunovant position as of Q2 2025 after selling out during the quarter.
  • Principal Financial Group sold 760,608 Immunovant shares in Q2 2025, an estimated $13M.
  • Principal Financial Group first reported a position in Immunovant in Q4 2020 and held it in 18 quarters.
  • Principal Financial Group's Immunovant position peaked at $27.1M in Q3 2024.
  • 168 funds tracked by Wall St. Rank held Immunovant as of Q2 2025.

Based on Principal Financial Group's 13F filing for Q2 2025, filed 8 Aug 2025.